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Mouse mammary tumour virus (MMTV) encodes a viral superantigen (Sag) and a negative acting factor (Naf) which share parts of their coding
sequence. Using 2-dimensional gel electrophoresis (2D-DIGE), we could show that at least 10 different cellular proteins were differentially
expressed in Naf positive cells. Also, luciferase reporter expression was down-regulated in Naf expressing cells independent of the promoter used
and further experiments suggested that this effect was due in part to a decrease in cellular growth rates. Although in Naf positive cells expression
of the major sag containing transcript was strongly induced by the synthetic glucocorticoid dexamethasone, the hormone analogue neither
influenced luciferase expression nor mRNA expression of selected cellular proteins identified by 2D-DIGE. Taken together, these data support the
previous finding that Naf and Sag have separable activities and suggest that Naf may play a role in modulating host cell gene expression during
MMTV infection.
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dissociation inhibitorIntroduction
The MMTVaccessory factor Naf was first discovered during
attempts to establish a packaging cell line for MMTV based
vectors. A clone of cat kidney cells (CrFK), which are permissive
for MMTV replication but free of endogenous MMTV, was
stably transfected with a packaging construct containing full-
length MMTV proviral sequences under the transcriptional
control of the Rous sarcoma virus (RSV) promoter and was
shown to produce large amounts of MMTV proteins (Salmons et
al., 1989). Interestingly, upon stable introduction of various
MMTV based retroviral vectors, expression levels of Gag
proteins were considerably reduced (Salmons et al., 1990). S1
protection assays showed that levels of correctly initiated
transcripts were reduced by approximately two thirds and
transcriptional run-on assays showed that the decrease of0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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reduced mRNA stability. These results suggested the existence
of a trans-acting negative regulator of transcription which was
subsequently termed Naf (Salmons et al., 1990). A luciferase
reporter assay system was established to allow easier analysis of
the Naf effect and shows that Naf also reduces expression from
heterologous viral promoters (Wintersperger et al., 1995).
MMTV also encodes for at least one other accessory factor, the
viral superantigen, Sag (Acha-Orbea and Palmer, 1991; Choi et
al., 1991). Introduction of a non-sense mutation intoMMTV sag
sequences abolished Naf activity but further analysis of the
coding requirements revealed that Naf and Sag were two
different factors since Naf requires sequences from the gag gene
whereas Sag does not (Salmons et al., 1990;Wintersperger et al.,
1995). Like Sag, Naf can be produced from either of the two
promoters located in the 5V long terminal repeat (LTR) (Salmons
et al., 2000). To date, however, it is unclear whether one single
gene product is responsible for the Naf effect or if two distinct
components are necessary. In addition, it is also unclear how Naf
mediates its effects on host cells.6) 139 – 150
www.e
C. Metzner et al. / Virology 346 (2006) 139–150140In this study, we identified genes differentially expressed
between cells expressing Naf and non-expressing cells by
differential 2 dimensional gel electrophoresis (2D-DIGE). In
addition, we could correlate the down-regulation of marker
gene expression to cellular growth rates. Taken together, our
data suggest that Naf induces differential expression which
subsequently causes a reduction in growth rate.
Results
Naf induces differential expression
To measure differences in protein expression patterns after
the stable introduction of the Naf expression construct, we
firstly used standard 2D gel electrophoresis with only one
sample per gel followed by silver staining to determine optimalFig. 1. (A) 2D gel electrophoresis followed by silver staining of protein extracted
expressed in 2D-DIGE. Approximate protein sizes (kDa) are indicated on the left and
proteins listed in panel C. (B) Overlay image from differential 2D analysis (2D-DIGE
and COE12 extract labelled with Cy5 (displayed in red) were used. The different flu
here. Spots of the same intensity for both colours/proteins appear yellow whereas
respectively. The fluorescence pattern of the pooled standard has been omitted to re
from separate gels therefore differences in protein patterns can occur. (C) Overview o
DIGE and identified by mass spectroscopy. Shown are proteins with a mean averag
COE12, CNOE14) and non-expressing (CrFK, CrFKc) cell lines. Both up-regulation
as well as the average change between the two groups as fold induction (negative va
observed mean differences of abundance of protein in the spot between groups and t
change are averages from several clones and do not necessarily match the overlay
question marks indicate unknown functions. ‘‘and’’ means two proteins could be ide
Accession numbers for the identified proteins are listed. All proteins are from humpI and molecular weight range for the combination of proteins
and gels we were using (Fig. 1A). These preliminary
experiments were performed in a pI range of 4–10 and
showed 30–50 spots to be differentially expressed when
comparing protein expression patterns from CrFK cells to
clones COE3 and COE12 generated by stable transfection of
CrFK cells with the Naf encoding construct pORFexp (data not
shown). The clones do not express functional Gag, Pro, Pol and
Env proteins, but have the potential to express the complete
Sag.
Subsequent experiments were carried out in a pI range of
4–7 to achieve better resolution in this area. To reduce
variation from experiment to experiment, 2D-DIGE was used
for further investigation. This technique uses fluorescently
labelled protein extracts and allows for the simultaneous
analysis of up to three complex protein mixtures (Van denfrom CK cells. Circled spots were identified as being significantly differently
isoelectric points (pIs) on the top. Spot numbers on the right correspond to the
). Equal amounts of CrFK protein extract labelled with Cy3 (displayed in green)
orescence patterns were determined and used to create the overlay picture seen
protein spots over-expressed in CrFK and COE12 will appear green and red,
duce the complexity of the picture. The pictures in panels A and B are derived
f the subset of gene products identified as being differentially expressed by 2D-
e difference of spot volumes greater than 1.25 between Naf expressing (COE3,
and down-regulation could be observed. Spot identification numbers are given
lues indicate down-regulation), the P value calculated by Student’s t test for the
he name and function of the identified protein. The given values for the relative
picture spot colour, which represents a single sample pair (CrFK/COE12). The
ntified from one spot. ‘‘or’’ means that both proteins have similar MS patterns.
an origin, except 1Sus scrofa and 2Bos taurus.
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extracted from cells were assigned to one of two groups.
Firstly, a group of cell lines not expressing Naf comprised of
CrFK and CrFKc cells. CrFKc cells are a mock transfected
stable population containing the empty cloning vector pcDNA3
and were included in the Naf-negative group to ensure that the
differential expression could not be attributed to the process of
transfection itself or the presence of sequences in the cloning
vector, such as the neomycin gene. Secondly, a Naf expressing
group, consisting of the clones COE3, COE12 and CNOE14,
stably transfected with the Naf expressing construct and
showing Naf functional activity was used. These clones show
comparable levels of functional Naf as determined by down-
regulation of luciferase activities (data not shown). A pooled
sample of all protein extracts was used as an internal standard
for all gels. Differentially expressed spots were analysed as
mean differences between the groups. In this way, any effects
of clonal variation on differential expression could be reduced.
Spots that showed a differential expression between the Naf
expressing and non-expressing groups of at least 1.25-fold
were selected. A t test was performed to calculate significance
of the mean differences of spot abundance between the groups.
The results of the 2D-DIGE can be visualised by overlay
images of the different fluorescence channels of the gels (Fig.
1B). To aid visualisation and interpretation, the channel for the
standard has been excluded from the presented image so that
only two of the three colours are shown. CrFK cells were
stained with Cy3 (Fig. 1B, represented in green) and COE12
cells with Cy5 (Fig. 1B, represented in red). Differentially
expressed spots would appear green (when over expressed in
CrFK cells) or red (when over expressed in COE12 cells) in the
overlay, whereas gene products expressed at similar levels
would appear yellow or orange. However, it should be noted
that visual analysis by the investigator only allows for rough
estimates of changes. Computational analysis allowed eva-
luation/quantification of spots according to their mean relative
changes between groups, statistical significance of the mean
differences between groups and appearance (Fig. 1C, ‘‘relative
change’’ and ‘‘t test’’, respectively). These criteria were used
for the initial selection of a set of spots which were
subsequently excised and subjected to MS/MS for identifica-
tion (Fig. 1C, ‘‘protein’’ section, see also Fig. 1A, circled
spots). PA28a, RhoGDI-1 and maspin amongst others were up-
regulated (Fig. 1C, upper section) and proteins such as
CRABP1 or the eIF5A were down-regulated (Fig. 1C, lower
section). Differences are expressed as fold change and negative
numbers are used to indicate down-regulation (Fig. 1C). An
induction of approximately 1.7-fold was the largest change
observed between Naf expressing and non-expressing cells;
levels of change between 1.26 and 1.7 were considered to be
significant by us as well as by others (Alfonso et al., 2005;
Lehr et al., 2005). The functions of the identified proteins vary
to a great extent (see Fig. 1C, column function).
To support the differential expression data and to assess the
influence of Naf on transcriptional regulation, Northern
analysis was carried out on total or mRNA extracted from
CrFKc cells, the Naf clones COE3, COE12 and CNOE14 aswell as 2C9 cells, a clone expressing genomic length MMTV,
encoding for all MMTV proteins. We were particularly
interested in changes at the transcriptional level as Naf was
described as a transcriptional repressor previously and we
hoped to be able to distinguish between transcriptional and
post-transcritional regulation. The changes between CrFKc and
the Naf clones relative to the quantity from specific transcripts
for the differentially expressed genes PA28a and RhoGDI-1
were determined (Fig. 2A, Northern) and compared to the
relative changes for the individual clones obtained from 2D-GE
(Figs. 2A, D). In both cases, the average change pointed
towards up-regulation of transcription for these genes, at levels
comparable to the ones observed with 2D-DIGE (Fig. 2A,
average). In the case of PA28a, the expression patterns from
2D gels could be reproduced by Northern analysis (compare
Fig. 2A, PA28a, NB and 2D sections for COE3, COE12 and
CNOE14) and a clear trend for up-regulation of expression was
visible (compare Fig. 2A, PA28a, averages). Induction of
expression was highest in cells expressing full-length MMTV
provirus (Fig. 2A, PA28a, 2C9). We could not reproduce the
2D differential expression data for RhoGDI-1 on the mRNA
level. Differences measured were close to 1 for the Naf clones,
with the exception of CNOE14 (compare Fig. 2A, RhoGDI-1,
COE3, COE12 and CNOE14). A representative Northern blot
(Fig. 2B) shows a clear difference between CrFK cells and
COE3 cells in the amount of PA28a transcript (compare Fig.
2B, upper panel, CrFKc and COE3) whereas no such
difference can be observed for the RhoGDI-1 transcripts
(compare Fig. 2B, lower panel, CrFKc and COE3). Samples
stimulated with dexamethasone gave approximately the same
signal intensities as non-stimulated, showing that the expres-
sion of RhoGDI-1 and PA28a is not inducible by dexameth-
asone (compare Fig. 2B,  and + lanes, respectively).
Naf down-regulates reporter gene expression irrespective of
promoter sequence and decreases transfection efficiency
A second strategy was employed to confirm the Naf effect
and its association with cellular functions. A luciferase reporter
system was established to screen reporter gene expression under
the transcriptional control of a range of cellular and viral
promoters. Cell lines, identical except for the presence of the
trans-acting factor Naf, were transiently supertransfected in
parallel with reporter constructs driven by the various promoters
and the levels of reporter gene expression were compared (Fig.
3A). The clones COE3 and COE12 were used to look for Naf
responsive promoters in a panel of viral (cytomegalovirus,
CMV; human immunodeficiency virus type 1, HIV-1; murine
leukaemia virus, MLV; MMTV) and cellular promoter
sequences (h-actin, BA; glucokinase, GK; carbonic anhydrase,
CA; tissue factor, TF; whey acidic protein, WAP) compared to
the Naf negative cells (CrFK). All constructs, regardless of
whether they carried viral (Fig. 3B, lanes CMV, MLV, MTV,
HIV) or cellular promoter sequences (Fig. 3B, lanes BA, GK,
CA, TF) were reproducibly down-regulated in Naf expressing
cells to levels that were between 20 and 40% of those obtained
from CrFK cells not expressing Naf (Fig. 3B, dotted line). In
Fig. 2. Summary differential expression. (A) The table shows relative changes in expression levels for PA28a and RhoGDI-1 in Naf expressing clones determined by
2D-DIGE and Northern blotting analysis. The 2D data represent the change of a single Naf clone (COE3, COE12 and CNOE14) relative to an average value for Naf
negative cells (CrFKc and 3 different preparations of CrFK in the case of PA28a and 2 different preparations of CrFK cells in the case of Rho-GDI). For Northern
blot analysis, total RNA from CrFKc and Naf clones was hybridised with probes specific for PA28a and RhoGDI-1. The intensities of specific bands were quantified
and the mean relative differences are given here. For the dexamethasone induction factor (dex), band intensities observed in samples stimulated with dex were
divided by band intensities from non-stimulated samples in Northern blotting analysis. The clonal expression patterns seen for PA28a in 2D and Northern blotting
analysis follow the same pattern and indicate a trend towards up-regulation in Naf expressing cells compared to the CrFK parental cell line. The strongest up-
regulation was observed for 2C9, a clone containing genomic length MMTV sequences. No trend for differential expression can be seen for RhoGDI-1 expression,
although the average change between Naf expressing and non-expressing cells matches the average change observed in the 2D. In addition, levels of expression of
either of the two proteins were not changed significantly by the presence of dexamethasone for any clone. Results from Northern blot analysis represent the mean
from 3 individual experiments, with the numbers in brackets showing the corresponding standard deviations. (B) Northern blotting analysis for differentially
expressed genes PA28a and RhoGDI-1. RNAwas extracted from CrFKc and COE3 cells stimulated and unstimulated with dex ( and + lanes, respectively). Equal
amounts of RNAwere used for Northern blots and membranes were hybridised to probes specific for PA28a (upper panel) and RhoGDI-1 (lower panel). For PA28a,
a clear increase of signal intensity between CrFK and COE3 cells is visible. No significant difference is visible between dexamethasone stimulated (+) and non-
stimulated () cells. No differences can be observed in the levels of RhoGDI-1 message produced in CrFKc and COE3 cells. As would be predicted, the sizes of
transcripts are approximately 1000 (PA28a) and 2000 (RhoGDI-1) nucleotides (nt). Relative intensities (RI) of the hybridised bands are given. The blot is a
representative example of a set of experiments used to determine the values for the data in panel A.
C. Metzner et al. / Virology 346 (2006) 139–150142support of previously reported data (Wintersperger et al., 1995),
both COE3 and COE12 showed a reduction in luciferase activity
to approximately the same levels (Fig. 3B, hatched and dotted
columns, respectively).
In subsequent experiments, the Naf clones COE3 and
COE12 were co-transfected with a luciferase and a CMV
driven eGFP expression reporter construct. Promoter regions
from HIV-1 (Fig. 4, lanes HIV), h-actin (Fig. 4, lanes BA) and
carbonic anhydrase (Fig. 4, lanes CA) were used to drive
expression from the luciferase reporter construct, whereas
eGFP expression was driven by the CMV promoter in all cases.
Cells were analysed by FACS analysis and luciferase mea-
surement in parallel. The percentage of cells transfected can be
determined by FACS and hence transfection efficiency can be
calculated. This can be used to standardise for the amount of
transfected (i.e. reporter expressing) cells. In addition to the
down-regulation of luciferase activities in the Naf expressing
clones (Fig. 4A, lanes HIV, BA, CA) in comparison to CrFK
cells (Fig. 4A, luciferase activity levels in CrFK cells is
indicated by the dotted line), we could also observe a decrease
of transfection efficiencies in Naf expressing clones COE3 and
COE12 regardless of the promoter driving luciferase reporter
(Fig. 4B, lanes HIV, BA, CA; transfection efficiency levels in
CrFK cells are indicated by the dotted line). This decrease intransfection efficiency was highly reproducible and not
accompanied by a down-regulation in mean fluorescence
intensity (MFI) of the transfected cells (Fig. 4C, lanes HIV,
BA, CA; mean fluorescence intensity levels in CrFK cells are
indicated by the dotted line), which appears to contradict the
data from the luciferase assays (Fig. 3B). However, this
observation can be explained by the fact that while in the
luciferase assay all cells are included in the measurement, only
the transfected cells are taken into account when measuring
MFI. Taken together, these observations suggest that the down-
regulation of luciferase activities in Naf clones is at least in part
due to less cells being transfected rather than a reduced
expression level, at least for CMV driven EGFP expression.
Naf reduces growth rates
Calcium phosphate transfection precipitates are taken up by
endocytosis, a process controlled by plasma membrane
proteins. Although we are measuring transfection efficiency
by means of expression of the eGFP gene, the results presented
above suggested that the down-regulation of expression seen in
Naf expressing cells may be due to the reduced uptake of DNA
into the cell during transfection. To test this hypothesis,
fluorescein labelled DNA was used for transfection of cells.
Fig. 3. (A) Experimental setup. All reporter gene assays were carried out according to the scheme shown here. Cells stably expressing the trans-acting factor of
interest, e.g. Naf (1), were transiently supertransfected with a luciferase or combination of luciferase and EGFP reporter constructs. In parallel, an equal amount of
the same transfection mix was used to transfect Naf negative CrFK cells (2). The experiments were analysed by luciferase assay or flow cytometry for EGFP (3).
The levels observed in the Naf negative cells were set to 100% and the levels in Naf expressing cells were expressed as percentages relative to this. (B) Naf and
heterologous promoters. Luciferase assays carried out on Naf clones COE3 and COE12 derived from CrFK cells by stable transfection with pORFexp. Experiments
were carried out according to the scheme in panel A. CrFK cells were used to define the 100% level, which is indicated by the dotted line. The tested viral
promoters (CMV, MLV, MMTV, HIV) as well as the cellular promoters (BA, GK, TF, WAP) both showed a down-regulation of luciferase activities of between 20
and 40% in both clones (COE3 hatched columns, COE12 dotted columns). The data represent the mean and standard deviations from at least three individual
experiments.
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necessary for detection of the transfected molecule, hence,
transfection efficiency is not dependent on cell division.
However, no difference in the percentage of fluorescent cells
could be observed when the Naf clones were compared to
CrFKc cells, which were set at 100% (Fig. 5A, rel. TE, hatched
and dotted columns, respectively). Mean fluorescence intensi-
ties (MFIs) seemed to be slightly lower, with the effect being
stronger in COE12 cells (Fig. 5A rel. MFI, hatched and dotted
columns, respectively); however, MFIs were generally low as
the labelled DNA is difficult to detect even by FACS analysis.
The results suggest that the uptake of fluorescently labelled
DNA, i.e. the endocytic activity of cells, is not affected by the
presence of Naf and that events occurring after the uptake of
DNA into the cells are responsible for the decrease in
transfection efficiencies observed in the dual reporter assays.
To further investigate this, metabolic activities of the cells were
determined by cellular redox enzyme activity using Alamar-
Blue. No difference in metabolic activity levels could be
observed between CrFKc cells (Fig. 5B, light columns) and
either of the Naf expressing clones COE12 (Fig. 5B, hatched
columns) or CNOE14 (Fig. 5D, dotted columns) at any of the
tested cell densities.
For successful expression of transfected DNA, transfer of
plasmid into the nucleus is necessary and this occurs passively
during the break-down of the nuclear membrane during
mitosis. In turn, this means that cell division is necessary for
successful transfection (Escriou et al., 2001; Zelphati et al.,
1999). Therefore, it may be that the reduced transfection
efficiencies in Naf expressing cells are due to a decrease ingrowth rates. In addition, some of the proteins identified after
2D-DIGE and MS are linked with growth control. To test this
hypothesis, we were interested to characterise the growth
kinetics of Naf expressing clones. In first experiments, absolute
cell numbers were plotted against time after seeding. As would
be expected, after a lag phase of about 24–48 h, the cells
started to grow; however, Naf negative CrFK cells (Fig. 5C, 0)
clearly grew faster than either of the Naf expressing clones
COE3 (Fig. 5C, n) or CoE12 (Fig. 5C, r). This can be
quantified by calculating doubling times. We determined the
doubling times of CrFKc and the Naf expressing clones COE3
and COE12 in comparison to CrFK cells and could observe a
1.5- to 2-fold increase in the time required for population
doubling of COE3 and COE12, respectively (Fig. 5D). CrFKc
cells showed the same doubling times as CrFK cells, indicating
that the presence of vector DNA alone did not affect the growth
characteristics of the cell lines. Comparable results were
obtained using two different methods for growth kinetics,
namely trypan blue exclusion (Fig. 5D, hatched columns) and
CASY cell counting (Fig. 5D, dotted columns).
Sag is dexamethasone inducible in Naf clones, but the Naf
effect and the associated differential expression of cellular
genes are not
The activity of the major MMTV promoter, P1, can be
strongly induced by dexamethasone (Gunzburg and Salmons,
1992; Hynes et al., 1983). We evaluated Sag expression by
Northern blot analysis using total RNA from Naf expressing
clones. As predicted from the Naf constructs used, a message of
Fig. 4. Dual reporter assay using luciferase and EGFP expression constructs.
The experiments were carried out according to the scheme in Fig. 3A. The Naf
clones COE3 and COE12 were supertransfected with luciferase constructs
driven by HIV, BA and CA promoters and additionally in each case also a
CMV driven EGFP expression construct in parallel. CrFK cells were used to
define the 100% level, which is indicated by the dotted line. The data represent
the mean and standard deviations from at least three experiments. (A) Results
from luciferase assays. A down-regulation of between 20 and 40% was
observed irrespective of the promoter used. COE12 cells (dotted columns) were
affected to the same extent as COE3 (hatched columns). (B) Results from flow
cytometry– transfection efficiencies. The transfection efficiency indicates the
percentage of transfected cells. The plotted values are relative to CrFK cells. A
down-regulation of between 20 and 60% was observed. COE12 cells (dotted
columns) were affected more strongly than COE3 cells (hatched columns). (C)
Results from flow cytometry–mean fluorescence intensities (MFIs). The MFI
indicates the average expression level of transfected cells. The plotted values
are relative to CrFK cells. No significant changes were observed although a
slight trend towards up-regulation of MFIs was seen. COE12 cells (dotted
columns) were affected to the same levels as COE3 cells (hatched columns).
C. Metzner et al. / Virology 346 (2006) 139–150144approximately 1700 nucleotides was visible, also in cells
containing a full-length genomic MMTV (Fig. 6A, lanes
COE3, COE12, CNOE14 and 102; sag transcript). The sag
message runs at the same size as the message derived from
pSVorfexp (data not shown), which carries the same sequences
from the 3V LTR of MMTV and was used previously for
functional studies of Sag (Wintersperger et al., 1995). In Naf
expressing clones, this message was strongly inducible by
dexamethasone by more than 20-fold (Fig. 6A, compare
COE3/+ and COE12/+ lanes). The amount of full-lengthmRNA in Naf clones (¨4000 nt) was not enhanced (Fig. 6A,
full-length) and neither was the level of an additional,
uncharacterised transcript in COE3 of about 3000 nucleotides
(Fig. 6A, extra). The dex induced increase in the 1700 nt sag
transcript clearly shows that the integrated Naf expression
construct in the clones can respond to dex induction. Transcripts
specific for the differentially expressed genes PA28a and
RhoGDI-1 were not dexamethasone inducible (Fig. 2B).
Luciferase reporter assays were carried out as described
earlier (see also Fig. 3A) to test whether the Naf effect, i.e. the
down-regulation of luciferase activity, was inducible by
dexamethasone. Transfected cells were stimulated with dexa-
methasone 18 h before harvesting. The level of reduction of
luciferase activity was not significantly altered in the presence
of dexamethasone in COE3 or COE12 clones (Fig. 6B,
compare COE3, COE12  and + lanes) irrespective of whether
a viral (e.g. RSV) promoter or a cellular (e.g. BA) promoter
(Fig. 6B) driving luciferase expression was used. These data
clearly show that the Naf effect is hormone independent. Since
the expression of the two analysed differentially regulated
cellular genes is also dexamethasone independent, this strongly
suggests that the differential expression we have observed upon
transfection of the Naf expression constructs is the result of Naf
expression rather than expression of hormone inducible Sag
from the same construct at least for the examined proteins.
However, if Sag expression was responsible for differential
expression, the induction after dex stimulation should have an
effect on differential expression. These results support previous
findings that Naf and Sag are different factors.
Discussion
To widen our understanding of Naf function, the effects of
the viral accessory factor on the host cell were studied using a
2D-DIGE proteomic profiling strategy. In this way, we hoped
to identify cellular functions affected by and proteins possibly
interacting with Naf. Indeed, a set of differentially expressed
gene products could be identified (Fig. 1C) which represent a
subset of the proteins that change in amounts between Naf
expressing and non-expressing cells. It is notable that the levels
of differential expression are generally quite low, with the
biggest difference being an approximately 1.7-fold increase in
comparison to the control group (Fig. 1C). However, this is in
fact in accordance with the previously reported Naf effect
which leads to a decrease of 2.5-fold in luciferase assays (Fig.
3B). It is likely that this effect is partly due to a reduced cell
growth rate. Cell lines expressing high levels of Naf, and
therefore showing higher differential expression of proteins,
will have a growth disadvantage that may even lead to
quiescence or cell death. This in turn makes it difficult to
select for cells with high expression of Naf. In support of this
hypothesis, we noticed during the production of Naf expressing
clones that far more dead cells were present than in the mock
transfected and control dishes and therefore that isolation of
Naf positive clones was a difficult task (data not shown).
An important factor to consider when studying Naf is that
the Naf expression constructs are also capable of expressing
Fig. 5. Growth kinetics and DNA uptake in Naf clones. (A) CrFKc cells and the Naf clones COE3 and COE12 were transfected with fluorescein labelled plasmid
DNA and analysed by flow cytometry. The percentage of cells representing the Naf expressing clones that took up labelled DNA (transfection efficiency, rel. TE)
was not changed in either clone compared to CrFK cells (hatched and dotted columns, respectively). The mean levels of fluorescein appeared to be slightly reduced
(rel. MFI). Values are relative to the levels in CrFK cells (100%). The data represent the mean and standard deviations from at least three experiments. (B) Cell
suspensions were incubated with AlamarBlue reagent at 37 -C to determine metabolic activities for CrFKc cells (light columns) and the Naf clones COE3 (hatched
columns) and COE14 (dotted columns). No differences were observed at any of the used cell densities between cell lines. RFUs are relative fluorescence units. The
clone CNOE14 was used rather than COE3 in this case as COE3 cells are physically larger which influenced the read-out from the AlamarBlue assay system. The
values represent averages and standard deviations from triplicates of data. (C) The graph shows the increase in absolute cell numbers with time for CrFK cells (CK 0)
and the Naf clones COE3 (n) and COE12 (r). The same number of cells was seeded and harvested after the stated time. Cells were counted and the absolute cell
numbers plotted against the hours post-seeding. Absolute cell numbers are lower for COE3 and COE12 than for CrFK. COE12 gives lower cell numbers than COE3.
The graph shows one representative experiment. (D) Doubling times (relative DTs) were calculated by harvesting cells at 72 and 120 h post-seeding and counting by
trypan blue exclusion (TB) and CASY technology for CrFK, CrFKc, COE3 and COE12 cells. Values are relative to the numbers observed for CrFK cells. No change
in doubling times was observed between CrFK and CrFKc cells but Naf clones COE3 and COE12 show increased doubling times, both when counted with TB
(hatched columns) and CASY (dotted columns). COE12 shows longer doubling times than COE3. The data represent the mean and standard deviations from at least
three experiments.
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could be due to the presence of either or both factors.
Therefore, it is always necessary to separate the function of
these two factors when studying Naf. It was seen that a
message of approximately 1700 nucleotides was strongly
inducible by dex (Fig. 6A, sag). Since this message is of a
similar size to that from the Sag expression constructs
pSVorfexp (Wintersperger et al., 1995) and pCSEneo (data
not shown) and messages of this length have been identified
in various mouse strains and have been implied to be sag
messages (Van Ooyen et al., 1983), we believe it is
reasonable to conclude that this transcript is indeed the
mRNA coding for Sag. In contrast, the full-length messages
present in Naf clones, of about 4000 nucleotides, were not
hormone inducible (Fig. 6A, full-length). Preliminary experi-
ments revealed that the expression of Naf responsive cellular
genes was not affected by dexamethasone treatment (Fig. 2B,
dex). In addition, also the down-regulation of luciferase
activity caused by Naf is not enhanced by the presence of
dexamethasone (Fig. 6B), clearly showing that these effects
are not mediated by Sag.Because Naf was originally described as having a
negative effect on transcription rates, we decided to use
Northern blot analysis for further investigation since this
may provide information about whether regulation of
expression occurs at a transcriptional or post-transcriptional
level. From the group of proteins identified by 2D-DIGE
(Fig. 1), we chose two for confirmation of differential
expression by Northern blotting analysis. RhoGDI proteins
are regulators of Rho GTPases that act by sequestering the
enzymes in their inactive GDP-bound form in the cytosol
and thereby inhibiting their activity (Olofsson, 1999). There
are three members of the RhoGDI family: RhoGDI-1 is
ubiquitously expressed, whereas the RhoGDIs 2 and 3 are
expressed preferentially in haematopoietic and brain cells,
respectively (Olofsson, 1999). Rho family GTPases form a
family of approximately 20 members in mammals, of which
RhoA, Rac and Cdc42 are the best studied. Rho proteins are
involved in the remodelling of the actin cytoskeleton in
response to extracellular stimuli. The over-expression of
RhoGTPases, especially RhoA, is a frequent and early event
in human cancer (Lin and van Golen, 2004). In theory, the
Fig. 6. Dexamethasone induction, Sag and Naf. (A) Shown is a Northern blot of total RNA using the indicated cell lines hybridised to a probe spanning the complete
sag ORF. Expression of sag was observed in COE3, COE12, CNOE14 and CrFK cells stably transfected with the genomic length provirus pGR102 (102).
Expression of a sag specific message of about 1700 nucleotides was induced strongly in COE3, COE12 and CNOE14 when dexamethasone was present (compare 
and + lanes). As a control for binding of the radiolabelled probe, signals for genomic (approximately 8500 nt), env (approximately 3500 nt) and sag messages can be
seen. Transcripts of about 4000 and 3000 nt visible in Naf clones (full-length and extra, respectively) are not inducible. The intensity of these signals is stronger for
COE3 than for COE12 and the ‘‘extra’’ band does not appear in COE12 or CNOE14. (B) Luciferase assays were carried out according to the scheme in Fig. 3A. 18 h
before harvesting cells were stimulated with dexamethasone. No change in luciferase activities could be found between cells stimulated (dotted columns) or non-
stimulated (hatched columns) with dex. This could be observed in Naf clones COE3 and COE12 for viral (RSV) and cellular (BA) promoters driving luciferase
expression. Values are relative to the level in CrFKc cells which is indicated by the dotted line. The data represent the mean and standard deviations from at least
three experiments.
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RhoGDIs should have an anti-tumourigenic effect. However,
the opposite seems to be the case: RhoGDIs are over-
expressed in a highly metastatic cell line (Jiang et al., 2003),
reduction of RhoGDI expression induces apoptosis (Mac-
Keigan et al., 2003) and RhoGDIs seem to be necessary for
Cdc42-mediated transformation of NIH 3T3 cells (Lin et al.,
2003). The differential over-expression of RhoGDI-1 observed
in our study was rather small and could not be confirmed by
Northern blot analysis. This may either be because expression
differences at the transcriptional level were too small to be
detected or that other factors affecting e.g. the synthesis or the
longevity of the protein play a role (Fig. 2A). In addition,
differential expression may be caused by post-transcriptional
regulation and therefore not appear in the Northern blot
analysis. Several studies applying proteomics methods to
cancer-related topics identified RhoGDIs as differentially
expressed (Jiang et al., 2003; MacKeigan et al., 2003). We
suggest that an up-regulation of RhoGDI-1 may lead to altered
cell skeleton dynamics, as was observed for over-expression of
Rho (Imamura et al., 1998). This in turn could change cellularmotility and proliferation characteristics by causing changes in
the downstream targets of Rho (Benitah et al., 2004).
Proteasome activator subunit 1 (PA28a, PSME1) is a major
part of the 11S (PA28) regulatory subunit of the proteasome
(Rechsteiner and Hill, 2005). It forms heteroheptameric
complexes together with PA28h that can interact directly with
the 20S core proteasome (Yamano et al., 2002). The HIV-1
accessory protein Tat was reported to compete with PA28a for
binding to the proteasome core (Huang et al., 2002). PA28a
and PA28h expression is inducible by IFNg and usually PA28
is expressed at high levels in professional antigen presenting
cells (Macagno et al., 1999), like B cells, which are a primary
infection target for MMTV. The function of PA28a is
associated with the generation of peptides that can be presented
via MHC Class I molecules, although generally PA28a is not
necessary for the normal processing of MHC I peptides, as
shown by in vivo experiments using PA28a/PA28h double
knock-outs. However, specific antigens, such as the murine
tumour-associated tyrosinase-related protein 2 (TRP2) are
solely dependent on PA28 for correct processing (Yamano et
al., 2002). The exact role of PA28a in MHC1-mediated
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subset of antigens requires the PA28 subunit of the proteasome.
It may be that degradation and presentation of viral or tumour
antigens like Sag could be dependent on high levels of PA28a
activity. By up-regulating the levels of this factor, Naf could
induce degradation of Sag, therefore inhibiting effective
expression of Sag on the cell surface and subsequent oligo-
clonal stimulation of T cells. We could reproduce the
differential expression pattern of clones observed in 2D-DIGE
in Northern blots (Fig. 2) and also results from suppression
subtractive hybridisation (SSH, data not shown) were support-
ive of these data. However, the contribution of PA28a to the
observed decrease in growth rates remains unclear, although
changes in proteasome activity can influence growth kinetics,
e.g. via targeted degradation of cyclins (Hershko, 1996; Obaya
and Sedivy, 2002).
Other genes identified by 2D-DIGE and MS constitute
interesting targets as well, for example the tumour suppressor
maspin, a serpin protease inhibitor that has been shown to
inhibit angiogenesis, tumour cell growth and invasion both in
vitro and in vivo (Schaefer and Zhang, 2003). Maspin may
therefore contribute to the observed decrease in growth rates of
Naf clones. Maspin enhances cell adhesion to the basement
membrane and extracellular matrix components. CRABP-1 and
the related CRABP-2 are regulators of retinoic acid (RA)
signalling (Giguere, 1994). RA is involved in the regulation of
cell proliferation, differentiation and apoptosis and its changed
regulation by the decrease of CRABP-1 expression in Naf
clones could also contribute to reduced growth rates.
As discussed above, several of the identified proteins could
be interfering with the growth behaviour of the cells. It is well
known that rather subtle changes in expression levels can
induce significant biological effects (Napoli et al., 2003; Choe
et al., 2005). However, it remains unclear whether these protein
changes alone are responsible for the decrease of growth rates
or whether other, as yet unidentified proteins that are
differentially expressed contribute to the slowing of growth.
These might include proteins directly involved with growth
regulation, such as cyclins or MAP kinases. Also additive
effects of several differentially expressed genes seem possible.
As demonstrated previously, Naf can act as a transcrip-
tional repressor and cause the down-regulation of expression
of luciferase from reporter constructs driven by different viral
promoters (Salmons et al., 1990; Wintersperger et al., 1995).
In addition to measuring differential expression at the protein
level using 2D-DIGE, we tested several cellular promoters in
luciferase reporter assays, amongst them the transcriptional
regulatory elements from the ubiquitously expressed house-
keeping gene h-actin and the mammary specific whey acidic
protein (WAP, Fig. 3B), to see whether Naf could also
influence expression of cellular genes at a transcriptional
level. The finding that all tested promoter elements were
affected to similar degrees (Fig. 3B) as well as the discovery
that Naf also decreases transfection efficiencies suggested
either a decrease in the capacity of cells for DNA uptake by
endocytosis or the less frequent degradation and formation of
nuclear membranes during mitosis. Both factors can have aninfluence on transfection by calcium phosphate precipitation.
We examined both characteristics and found that while uptake
of DNA was not affected (Fig. 5A, TE section), growth rates
were decreased for Naf clones when compared to Naf non-
expressing cell lines (Fig. 5D). In addition, we analysed
metabolic activities of Naf clones relative to parental cells and
could find no difference, indicating that the overall cellular
energy balance is not markedly disturbed. Reduced growth rates
will reduce transfection efficiencies because less vector DNA
can enter the nucleus and become expressed. As a consequence,
less cells amongst the pool used for luciferase assays will
express the reporter gene and since this assay does not
discriminate between transfected and non-transfected cells, this
will ultimately lead to lower luciferase activities, as was
observed. This will not affect MFIs as this parameter only
takes transfected cells into account. We propose that the change
in growth rates is responsible for the down-regulation of
luciferase activities and transfection efficiencies in the dual
reporter assay. This will mask any promoter specific effect of
Naf in luciferase assays. Additionally, the Naf-mediated effect
on transcription seems to require stable expression of both Naf
and the target (Salmons et al., 1990; Wintersperger et al., 1995)
therefore transient supertransfection with the reporter construct
might not be sufficient for transcriptional down-regulation.
Taken together, our observations strongly suggest that Naf is
a factor independent from Sag that in addition to its function as
a transcriptional repressor of retroviral genomes can mediate
differential expression of host genes, which in turn has an
effect on host cell growth kinetics. Retroviruses are known to
encode accessory factors to modulate gene expression to suit
their needs, like HIV Nef, which down-regulates expression of
the HIV receptor CD4 (Garcia and Miller, 1991) and MHC
class I molecules (Schwartz et al., 1996). However, the exact
nature and the biological relevance of Naf function itself still
remain unclear. MMTV needs to adapt to different cellular
surroundings during infection. Naf might only be expressed at
certain times in the viral life cycle and only in certain cell
types. As expression patterns vary from cell type to cell type, it
will be important for evaluating Naf effects on differential
expression to extend research to cells infected by MMTV in
vivo especially murine mammary and B cells and this is
currently being investigated.
We can only speculate upon a possible function of Naf in a
biological context here but early publications concerning
MMTV Sag also proposed a negative acting regulatory factor
(Beutner et al., 1992) to control superantigen activity. It seems
reasonable that such a regulator would share coding regions
and promoter usage with Sag, as over-expression of one would
probably also generate higher levels of the other, thus
generating a negative feedback loop. Alternatively, Naf might
be used to keep infected cells in an anti-proliferative state, to
prevent early onset of MMTV-related tumourigenesis. Another
possible explanation is that Naf contributes to viral latency by
allowing only minimal viral genetic programmes to be carried
out, similar to the way alphaherpesviruses persist (Daheshia et
al., 1998) as well as inducing cellular quiescence to support
latency. In addition, Naf expression could be a prerequisite for
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mechanism by which MMTV previously became endogenous.
Material and methods
Vector DNA
pGR102 and pORFexp have been previously described
(Salmons et al., 1985; Wintersperger et al., 1995). The
plasmid pGR102 contains a full hybrid provirus sequence
capable of expressing all MMTV proteins. pORFexp was
derived from pGR102 by deletion of a NcoI-fragment which
removes large portions of the gag and env and the complete
pro and pol ORFs. pcDNA3 was purchased from Invitrogen.
pMLVluc, pHIVluc, pMtv9luc and pB-actinluc have been
previously described (Wintersperger et al., 1995) and contain
the luciferase reporter gene sequence under the transcriptional
control of murine leukaemia virus (MLV), human immuno-
deficiency virus (HIV), MMTV and h-actin promoter regions.
Luciferase expression constructs pCMVluc, pWAPluc,
pGKlucCz, pCAlucCz and pTFlucCz carry promoter
sequences from cytomegalovirus (CMV), whey acidic protein
(WAP), glucokinase (GK), carbonic anhydrase (CA) and
tissue factor (TF), respectively. pCMVEGFP was derived
from pcDNA3 by introduction of the enhanced green
fluorescent protein (EGFP) gene into the multiple cloning
site (Walter et al., 2000).
Cell clones
All stable cell lines were based on Crandell feline kidney
(CrFK) cells (Crandell et al., 1973). CrFK cells are one of few
cell lines permissive for MMTV infection but do not carry
endogenous copies of MMTV and in addition are easily
transfectable by various methods. Clones COE3 and COE12
are stable clones of CrFK cells transfected with pORFexp
(Wintersperger et al., 1995). 2C9 and CNOE14 are clones
derived after stable transfection of CrFK cells with pGR102
and pORFexp, respectively. CNOE14 contains the whole viral
gene cassette from pORFexp as determined by Southern blot
and was shown to display Naf activity measured by the
luciferase reporter system at a comparable level to Naf clones
COE3 and COE12 (data not shown). CK102 and CrFKc are
populations of CrFK cells stably transfected with pGR102 and
the neomycin resistance gene, respectively. All cell lines were
cultured in Dulbecco’s modified Eagle’s medium (DMEM)
containing 5% fetal calf serum. For selection, 400 Ag/ml of the
neomycin derivative G418 (Life Technologies) was added to
the culture medium. Dexamethasone stimulation was carried
out in a final concentration of 106 M for 18 h.
Transfections
Transient
Cells seeded at 5  105 cells per 6-cm dish were transfected
with 3 Ag of luciferase reporter plasmid or for co-transfection
with 3 Ag luciferase plasmid plus 300 ng of pCMVEGFP bycalcium phosphate precipitation according to the manufac-
turer’s instructions (GE Health Care).
Stable
CrFK cells seeded at 1  106 cells per 10 cm dish were
transfected using 10 Ag of expression plasmid and 1 Ag of
pcDNA3 for selection using G418. After transfection, the cells
were washed, trypsinised and replated in medium supplemen-
ted with 400 Ag/ml G418.
2D differential gel electrophoresis (2D-DIGE)
Cell pellets were lysed in 30 mM Tris–HCl, 9 M urea, 4%
CHAPS (w/v), pH 8.5, using 7  107 cells per ml lysis
solution. Protein content was determined by Coomassie G-250
protein binding assay (Bradford, 1976). Samples were then
diluted in lysis puffer and labelled with CyDyes (GE Health
Care, formerly Amersham Biosciences) according to the
instructions of the manufacturer (8 nmol dye/mg protein).
Two labelled samples (Cy3, Cy5) and a sample pool (internal
standard, Cy2) were mixed and run on one gel. Classical 2D-
GE was performed in accordance to existing protocols (see
http://www.expasy.ch/ch2d). 25 Ag per labelled sample was
applied cathodically to laboratory-made linear IPGs pH 4–7
(of 10 cm length and run on a Multiphor system (GE Health
Care)) until 15 kVh was reached. The IPG strips were made
according to LKB Manual (LKB 2117 Multiphor Electropho-
resis System, LKB Produkter AB, Sweden, 1986, pp. 70–82).
After equilibration, strips were transferred to an SDS-PAGE gel
(T = 10–15% linear gradient, C = 2.7%) according to Laemmli
(1970) for the second dimension in a Hoefer SE 600 vertical
electrophoresis chamber (GE Health Care). For fluorescence
detection, 2D-GE gels were scanned on a Typhoon 9400
imager and evaluated with DeCyder Software V5.02 (all GE
Health Care). Protein spots differentially expressed between the
two sample groups (controls/transfected cells) were looked for,
using volume ratios and student’s t test as selection/discrim-
ination criteria. For protein identification of single spots by
means of mass spectrometry methods, protein patterns in 2D-
GE were detected by a modified silver staining according to
Heukeshoven (Miller and Gemeiner, 1992), omitting glutaral-
dehyde in the sensitising solution and formaldehyde in the




The respective spots were cut out from the gel with a
scalpel, transferred to reaction vials and dehydrated with
acetonitrile. In-gel protein reduction, alkylation and trypsina-
tion were performed as described previously (Zenzmaier et al.,
2005).
nano-HPLC-MS/MS protein sequencing
All nano-HPLC separations were performed on the UltiMate
system from LC Packings (Amsterdam, Netherlands). The
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detection unit, the Switchos A-column-switching device with
loading pump, two 10-port valves for pre-concentration and the
FAMOS A-autosampler. Eluting peptides were directly intro-
duced into the MS and ionised via Pico Tip (New Objective,
Cambridge, USA) to be further transferred online to a heated
capillary of an ion trap mass spectrometer (LCQ Deca XPplus,
Thermo Finnigan) as described previously (Zenzmaier et al.,
2005). Analysis of MS/MS spectra with respect to peptide
identity was routinely performed by applying both the
MASCOT (Perkins et al., 1999) (Matrix Science) and the
SEQUEST (Eng et al., 1994) (Thermo Finnigan) search
engines. A peptide was reliably identified only if the individual
peptide score was 40 (Mascot) and 3 for triply charged
peptides and 2.5 for double charged peptides (Sequest),
respectively.
Generation of probes
Specific target gene sequences for use as probes for
Northern blots were generated by RT-PCR. 5 Ag of total
RNA was used as template for cDNA synthesis using
Superscript II reverse transcriptase (Invitrogen), according to
the manufacturer’s instructions. The following primers were
used for RT-PCR: FPA1 (5V-ggagccagctctcaatgaag-3V) and
RPA1 (5V-cggatctccatgaccatcag-3V) for the proteasome activator
subunit 1 (PA28a); FRDI1 (5V-atgagcactcggtcaactac-3V) and
RRDI1 (5V-tcagtccctccagtccttct-3V) for the rho GDP dissociation
inhibitor 1 (RhoGDI-1). Primers (VBC Genomic, Vienna) were
designed based upon gene sequences derived from BLAST
searches and PCR fragments were sequenced (VBC Genomic,
Vienna) to confirm the correct sequence.
Northern blot analysis
Total RNA was prepared using the Qiagen RNeasy and
QiaShredder kits and mRNA was prepared using the Amer-
sham Quickprep Micro mRNA purification kit according to the
manufacturer’s instructions. 25 Ag of total RNA (1–4 Ag of
mRNA) per sample was run on 1.2% agarose gels containing
formaldehyde in 1 MOPS (19.7 mM 3-(N-morpholino)
propane sulphonic acid, 8 mM sodium citrate trihydrate, 1
mM EDTA) as running buffer. Gels were blotted overnight in
5 SSC onto Amersham Hybond N+ membranes. Hybridisa-
tion was carried out at 65 -C overnight using Amersham
RapidHyb hybridisation buffer. Blots were developed using
FugiScreen Imaging Plates (BAS-MP 2040S, Fuji) and
analysed using a Storm 860 imager (GE Health Care). For
quantification of bands, ImageQuaNT software (Molecular
Dynamics) was used.
Methylene blue staining
Membranes were stained in 0.04% methylene blue (Sigma)
dissolved in 0.5 M sodium acetate (pH 5.5) for 15 min and then
destained in distilled water. The stained membranes were
scanned and bands were quantified as described for Northernblot analysis. The intensities of the bands of 18S rRNA were
used to standardise intensities of bands after hybridisations.
Luciferase assays
Cell protein extracts were prepared 48 h after transfection.
Protein concentration was measured using the DC protein assay
according to the manufacturer’s instructions (BioRad) and 20
and 10 Ag of total protein were used for the luciferase assay. A
Berthold AutoLumat LB953 was used for measuring luciferase
activities which were calculated as percentages relative to
levels observed in CrFK or CrFKc cells.
Growth curves
To establish the assay system, cells seeded at 2  105 in
10-cm dishes were counted after 4, 24, 48, 72 and 120 h using
trypan blue exclusion. For the calculation of doubling times,
cells were seeded as above, but only harvested at 72 and 120
h. 50 Al of cell suspension was mixed with an equal volume
of 0.4% trypan blue solution (Sigma) and counted using
haemocytometer slides (Megumed Diagnostics). In addition, a
CASY Model TT (Scha¨rfe Systems) was used for counting.
AlamarBlue metabolic assay
AlamarBlue (TREK diagnostic systems) was used for
measuring metabolic activity. 1/10th volume of AlamarBlue
reagent was added to cell suspensions and incubated for 6 h at
37 -C. The samples were measured using a plate reader
(Genios, TECAN). Fluorescence was measured at 590 nm.
Fluorescein labelling of plasmid DNA
Plasmid DNA was labelled with fluorescein using the
FluoroULS kit (FermentasMBI) according to the manufac-
turer’s protocol. The labelled DNA was used for transfection
using 1 Ag of labelled DNA and measured by FACS analysis.
Flow cytometry (FACS)
Cells were sorted using a Becton and Dickinson
FACSCalibur flow cytometer. FACS analysis was performed
on 10,000 events per sample. Populations to be analysed
were defined by forward/side scatter dot blot cytograms. The
results were analysed using the Cell Quest Pro software
(BectonDickinson).
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